HomeProductsBioactive CompoundsNeuronal SignalingQCVaroglutamstat
Chemical structure of CAS 1276021-65-8

Varoglutamstat

CAS No.1276021-65-8
MDL No.N/A
MFC19H20N4O2
MW336.40
InChI KeyXHIKZWOEFZENIX-GOSISDBHSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1276021-65-8
Product NameVaroglutamstat

Associated Conditions

Alzheimer disease
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Development of a potent benzonitrile-based inhibitor of glutaminyl-peptide cyclotransferase-like protein (QPCTL) with antitumor efficacy.

Signal transduction and targeted therapy • Vol. 8, Issue 1 • 2023
PMID: 38097557PMC: PMC10721786DOI: 10.1038/s41392-023-01715-x

Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease.

Frontiers in aging neuroscience • Vol. 15 • 2023
PMID: 37600512PMC: PMC10435661DOI: 10.3389/fnagi.2023.1209863

Glutaminyl cyclases, the potential targets of cancer and neurodegenerative diseases.

European journal of pharmacology • Vol. 931 • 2022
PMID: 35948163DOI: 10.1016/j.ejphar.2022.175178

Glutaminyl Cyclase Inhibitor PQ912 Improves Cognition in Mouse Models of Alzheimer's Disease-Studies on Relation to Effective Target Occupancy.

The Journal of pharmacology and experimental therapeutics • Vol. 362, Issue 1 • 2017
PMID: 28446518DOI: 10.1124/jpet.117.240614

Documentation